SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS ARIPIPRAZOL (ABILIFY MAINTENA JERINGA PRECARGARGA) Y DECITABINA/CEDAZURIDINA (INAQOVI).
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- Apr 22,Expired
- Award
Brief
El Servicio Madrileño de Salud, Hospital Universitario La Paz, ha adjudicado un contrato a Otsuka Pharmaceutical S.A. para el suministro de medicamentos exclusivos Aripiprazol (Abilify Maintena jeringa precargada) y Decitabina/Cedazuridina (Inaqovi). El contrato tiene una duración de 12 meses y un valor final de 256.981 €.
Farmasøytisk engroshandel
Result
- OTSUKA PHARMACEUTICAL S.A.Winner
- 1Number of tenders received
- €256,981Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Servicio Madrileno de Salud, Hospital Universitario La Paz
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Coste
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS ARIPIPRAZOL (ABILIFY MAINTENA JERINGA PRECARGARGA) Y DECITABINA/CEDAZURIDINA (INAQOVI).
Contact
contratacion.hulp@salud.madrid.org- Result · PrequalificationType
- MadridLocation
- 33600000Main codePharmaceutical products